Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Calculate exactly how many units of Tirzepatide to draw on your syringe. Pre-filled with standard defaults.
Draw on your syringe
100
units
(1.000 mL)
100.0% of syringe capacity
Concentration
2,500
mcg/mL
Dose volume
1.000
mL
Doses per vial
2
doses
Cost per dose
---
enter price
Total mcg in vial = 5 mg x 1000 = 5,000 mcg
Concentration = 5,000 mcg / 2 mL = 2,500 mcg/mL
Dose volume = 2500 mcg / 2,500 mcg/mL = 1.0000 mL
Units to draw = 1.0000 mL x 100 units/mL = 100 units
Doses per vial = 5,000 mcg / 2500 mcg = 2 doses
Want the full Disclosed Trust Index?
Create a free account to unlock vendor trust scores, the COA scanner, the Forgery Map, and lot lookup across the corpus.
Create a free accountTirzepatide is a unimolecular dual GIP and GLP-1 receptor agonist FDA-approved as Mounjaro for type 2 diabetes (2022), Zepbound for chronic weight management in adults with obesity or overweight with a weight-related comorbidity (2023), and Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity (2024). It has a half-life of approximately 5 days, allowing once-weekly subcutaneous dosing.
Common vial size
5
mg
Typical BAC water
2
mL
Dose range
2500–15000
mcg
Default dose
2500
mcg
Store refrigerated (2-8°C). Once reconstituted, use within 28 days.